|

SYN818 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd1

Indications

  • HRR Deficiency1
  • Advanced Solid Cancer1
  • BRCA Mutation1
  • Metastatic Solid Tumor1
  • Ovarian Cancer1

Other1 trial

Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.